Journals / Turkish Journal of Gastroenterology / 2012 / Cilt: 23 - Sayı: 1

Özefagus hariç tüm gastrointestinal sistemi tutan ekstranodal marjinal zon B-hücreli lenfoma: Vaka sunumu

Extranodal marginal zone B-cell lymphoma of the gastrointestinal tract sparing only the esophagus: A case report

Pages
58–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

He underwent six courses of chemotherapy with R-CHOP regimen, and achieved complete remission.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lymphomas presented in any organ or tissue other than lymph nodes or the spleen are considered primary extranodal non-Hodgkin’s lymphomas, and the most common non-Hodgkin’s lymphomas are of the gastrointestinal tract.
📊
Key Findings & Data:Herein, we report the case of a 76-year-old male with extranodal marginal zone B-cell lymphoma involving the entire gastrointestinal tract, sparing only the esophagus, who was Helicobacter pylori-negative.
💡
Conclusion & Impact:He underwent six courses of chemotherapy with R-CHOP regimen, and achieved complete remission.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Yaşlı · Erkek · Gastrointestinal kanal

Abstract

Lymphomas presented in any organ or tissue other than lymph nodes or the spleen are considered primary extranodal non-Hodgkin’s lymphomas, and the most common non-Hodgkin’s lymphomas are of the gastrointestinal tract. The most common histological subtypes are marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue and diffuse large B-cell lymphoma, and typically only one to two organs are affected. Patients present with a wide variety of vague complaints, making early diagnosis problematic. Herein, we report the case of a 76-year-old male with extranodal marginal zone B-cell lymphoma involving the entire gastrointestinal tract, sparing only the esophagus, who was Helicobacter pylori-negative. He underwent six courses of chemotherapy with R-CHOP regimen, and achieved complete remission.

Özet

Lenf bezlerini veya dalağı tutmaksızın herhangi bir organ tutulumu ile prezente olan lenfomalar primer ekstranodal non-Hodgkin lenfomalar olarak kabul edilir ve gastrointestinal sistemde en sık görülen lenfoma tipidir. En sık görülen histolojik alt tipleri mukoza ilişkili lenfoid dokunun marjinal zon B-hücreli lenfoması ve diffüz büyük B hücreli lenfomadır, ve tipik olarak bir ya da iki organ tutulumu ile seyrederler. Hastalar çok çeşitli silik semptomlar ile prezente olurlar ve bu nedenle erken tanıda problemlerle karşılaşılabilir. Burada, Helikobakter pylori negatif olan 76 yaşındaki erkek hastada, özefagus hariç tüm gastrointestinal sistemi tutan ekstranodal marjinal zon B-hücreli lenfoma hastası sunulmuştur. Hasta 6 kür R-CHOP kemoterapisi almıştır ve halen tam remisyonda izlenmektedir.

🔖

Cite This Article

LAI, H. W., LIN, C., TSAI, M., CHEN, T., TSENG, S., CHANG, H., CHEN, T. (2012). Özefagus hariç tüm gastrointestinal sistemi tutan ekstranodal marjinal zon B-hücreli lenfoma: Vaka sunumu. Turkish Journal of Gastroenterology, Cilt: 23 - Sayı: 1, 58–62. https://ajindex.com/articles/409639

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol 2008; 19: 1992-9
  2. Sagaert X, Tousseyn T. Marginal zone B-cell lymphomas. Discov Med 2010; 10: 79-86
  3. Ahmad A, Govil Y, Frank BB. Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 2003; 98: 975-86
  4. Radic´-Kristo D, Planinc-Peraica A, Ostojiç S, et al. Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics. Coll Antropol 2010; 34: 413-7
  5. Rooney N, Dogan A. Gastrointestinal lymphoma. Curr Diagn Pathol 2004; 10: 69-78
  6. Kahl BS. Update. Gastric MALT lymphoma. Curr Opin Oncol 2003; 15: 347-52
  7. Kahl B, Yang D. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL. Hematology Am Soc Hematol Educ Program 2008; 359-64
  8. Sagaert X, Van Cutsem E, De Hertogh G, et al. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol 2010; 7: 336-46
  9. Zwick C, Murawski N, Pfreundschuh M. Rituximab in high-grade lymphoma. Semin Hematol 2010; 47: 148-55
  10. Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 2003; 63: 803-43
  11. Nückel H, Meller D, Steuhl KP, Dührsen U. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 2004; 73: 258-62.